Targeting CDK2 Confers Vulnerability to Lenvatinib Via Driving Senescence in Anaplastic Thyroid Cancer.
Ma B, Sang Y, Du X, Zhang Y, Yin M, Xu W, Liu W, Lu J, Guan Q, Wang Y, Liao T, Wang Y, Xiang J, Shi R, Qu N, Ji Q, Zhang J, Ji D, Wang Y.
Ma B, et al. Among authors: liu w.
Adv Sci (Weinh). 2024 Dec 24:e2413514. doi: 10.1002/advs.202413514. Online ahead of print.
Adv Sci (Weinh). 2024.
PMID: 39716890